Keywords: enbrel, enter, phase, ii/iii, heart, failure, immunex

Enbrel to enter Phase II/III for heart failure

Article | 11 March 1999

Print This

Immunex and Wyeth-Ayerst's rheumatoid arthritis treatment Enbrel(etanercept) has shown promise in a Phase I study in patients with congestive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in